Recent Updates Page 2 RSS Back to NoCamels

  • mayay 5:44 pm on November 26, 2014 Permalink
    Tags: , chinese investment partners, , , hermed fund, ,   

    Fosun Pharma Seeks Out Israeli Investment Partner 

    fosunNovember 26, 2014 | The venture capital arm of Chinese pharmaceutical company Fosun Pharma, the Hermed Fund, is seeking out a strategic investment partner in Israel and are considering investments in Israeli companies. The pharmaceutical daughter company of Chinese giant Fosun, worth approx. $8 billion, acquired Israeli startup Alma Lasers for $240 million and made investments in Check-Cap and Tyto Care. In addition, the Hermed Fund is considering partnering with a local fund or investment entity that will act as its representative within Israel. Fosun focuses the majority of its efforts on developing generic drugs, biosimilars, diagnosis mechanisms and health services.

  • mayay 5:36 pm on November 26, 2014 Permalink
    Tags: how much traffic is on a website, , , similarweb funding, sites like alexia, , traffic analysis   

    Traffic Analysis Website SimilarWeb Raises $15M In Series D Funding 

    SimilarWebNovember 26, 2014 | The Israeli digital insight and website traffic analysis company SimilarWeb announced that they raised $15 million in Series D funding. The report comes just nine months after the growing company, with 95 employees, raised $18 million in their Series C round. The latest funding round was led by Naspers and Lord David Alliance, bringing SimilarWeb’s total financing to $40 million since its founding 2009 by CEO Or Offer and Nir Cohen. The company hopes to use the funds to increase the pace of its global expansion, which includes growing their mobile capabilities and acquiring more mobile-geared companies.

  • mayay 12:16 pm on November 26, 2014 Permalink
    Tags: apostherapy, apostherapy funding, , , knee and back therapy shoes, therapeutic shoes   

    Knee And Bank Pain Therapy Co. AposTherapy Raises $15M 

    AposTherapyLogoNovember 26, 2014 | The Israeli knee and back pain therapy company, AposTherapy, announced that it raised $15 million in a recent funding round, at a $100 million company valuation, after money. Existing investors Pitango Venture Capital, Aviv Venture Capital and Invus participated in the funding round, along with private US investors, including David Levy from PricewaterhouseCoopers, among others. To date, AposTherapy has raised $30 million, with the company marketing its shoe knee and back pain therapies in Israel, the UK, US, Singapore and other countries. AposTherapy was founded in 2004 by Dr. Amit Mor and Dr. Avi Elbaz and currently treats 50,000 patients worldwide.

  • mayay 3:35 pm on November 25, 2014 Permalink
    Tags: airbnb of hotel rooms, disruptive capital, , , roomer series a funding, solutions for cancelled hotel rooms,   

    Roomer Raises $5M In Series A Funding From Disruptive 

    RoomerNovember 25, 2014 | The Airbnb of hotel rooms, Roomer, announced that it raised $5 million in a Series A financing round led by Disruptive. Roomer’s platform hopes to maximize on the over 81 million hotel room cancellations in the US alone by letting users sell their unwanted hotel room at a discounted price, saving them hefty cancellation fees. Fifteen percent of each hotel room re-sale goes to Roomer and the company claims that the average discount on a room near 37 percent for its users. The company, founded by Gon Ben-David and Ben Froumine, hopes to use the funds will help it build up supply and demand for its service and expand marketing.

  • mayay 2:12 pm on November 25, 2014 Permalink
    Tags: bill and melinda gates foundation, gates foundation, gates foundation israel, hervana, , paulee tec,   

    Bill & Melinda Gates Foundation Announces New Terms For Funding 

    billandmelinagatesNovember 25, 2014 | The Bill and Melinda Gates Foundation announced that beginning on January 1, 2015, all research that receives funding from the organization will be required to submit to open access journals. Over a period of two years, some aspects of this new requirement can be waived, however by 2017, all research must be made open from the start of funding. In addition, all published articles by Gates Foundation-supported researchers must have a Creative Commons Attribution 4.0 License, which allows all content to be reproduced, even commercially. A number of Israeli researchers and startups have received support from the Gates Foundation, such as the Paulee CleanTec and Hervana, and the latest decision may impact their partnership.

  • mayay 1:57 pm on November 25, 2014 Permalink
    Tags: baidu, , , , naftali bennett, robin li israel,   

    Report: Baidu Founder Robin Li To Visit Israel 

    baiduNovember 25, 2014 | According to a report by “Calcalist,” the founder of the popular Chinese search engine Baidu, Robin Li, will arrive in Israel after being invited by Minister of the Economy, Naftali Bennett. Bennett met with Li during his visit in China and invited him to visit Israel to discuss cooperation with local Israeli companies.

  • mayay 1:30 pm on November 25, 2014 Permalink
    Tags: china cleantech, don ye, israel cleantech, , , tsing capital, tsing capital israel   

    Report: Tsing Capital To Invest In Israeli Cleantech By End Of Year 

    Tsing-Capital-logoNovember 25, 2014 | According to a “Globes” report, one of China’s largest social investment funds Tsing Capital will make at least one investment in an Israeli cleantech company by the end of the year. “Globes” reports that the investment is set to amount to millions of dollars in an Israeli startup, according to statements made by the founding managing partner of Tsing Capital, Don Ye, at a conference in Haifa. Ye also reported that by next year, for the first time in history, China’s total investment in other countries would exceed the amount invested in China by other countries. Ye believed that cleantech is an up-and-coming sector for Chinese investment in Israel.

  • mayay 1:08 pm on November 25, 2014 Permalink
    Tags: , avi reichental, cimatron acquisition, danny haran, ,   

    Cimatron Acquired By 3D Systems For $97M 

    CimatronNovember 25, 2014 | The Israeli company Cimatron reports that it was acquired by the global integrated solutions 3D printing company 3D Systems for $97 million. The American company, based in South Carolina, acquired Cimatron for $8.97 a share, a price lower than the peak share prices Cimatron saw earlier in the year. 3D Systems is traded at a $3.9 billion market cap on the New York Stock Exchange, and according to the company’s announcement, the acquisition “will bolster the latter’s [3d System’s] standing in the rapidly growing design segment.” Cimatron is a product design software developer headed by CEO and President Danny Haran. 3D Systems is managed by former Israeli, CEO and President Avi Reichental.

  • mayay 12:44 pm on November 25, 2014 Permalink
    Tags: EE Off Grid Hub, eilat-eilot green energy conference, , , israel green energy, israel solar energy, timna solar park   

    Eilat-Eilot Green Energy Conference To Discuss Growth Of Sustainable Energy 

    eilateilotlogoNovember 25, 2014 | The Eilat-Eilot Renewable Energy Initiative will hold its 6th International Green Energy Conference on December 7-9 in Eilat, Israel. In addition to a number of panels on green energy topics, the conference will inaugurate the EE Off Grid Hub, a new technology hub that focuses on the development of products and technologies to provide energy, water and agriculture needs for populations in developing countries. The Timna Solar Park in Southern Israel will also be discussed, which is expected to produce up to 60 megawatts of solar power, based on PV tracking systems. The Eilat-Eilot Renewable Energy Initiative was established with a mission to develop sustainable energy in Israel.

  • mayay 1:43 pm on November 24, 2014 Permalink
    Tags: , biondvax ipo, , ,   

    Israeli Creators Of Universial Flu Vaccine, BiondVax, Mull Wall Street IPO 

    BiondVax Logo4November 24, 2014 | The Israeli biopharmaceutical company developing a universal influenza vaccine, BiondVax, is considering a Wall Street IPO, according to a “Globes” report. The company currently has a market cap of NIS 42 million (approx. $10.8 million) on the Tel Aviv Stock Exchange, which it hopes to maintain in a potential American offering. BiondVax’s universal flu vaccine, to treat a number of prominent flu strains, has already undergone a successful Phase II clinical trial and further trials will take place in 2015. BiondVax was founded in 2003 by its CEO Ron Babecoff.

compose new post
next post/next comment
previous post/previous comment
show/hide comments
go to top
go to login
show/hide help
shift + esc